Previous studies have shown that ATM gene polymorphisms are associated with poor prognosis of patients with pancreatic cancer, acute myeloid leukemia, and colorectal cancer [27, 28, 29]. The gene discussed is ATM; the disease is familial pancreatic carcinoma.